Cargando…

Abstract: Belatacept and Rapamycin with Short-Term Use of Tacrolimus Delay Allograft Rejection in a Novel, Large Animal Vascularized Composite Allotransplantation Model

Detalles Bibliográficos
Autores principales:	Elgendy, Tarek, Kim, Deokyeol, Waldner, Matthias, Zhang, Wensheng, Zahorchak, Alan, Minervini, Marta, Washington, Kia M., Ezzelarab, Mohamed, Solari, Mario G., Thomson, Angus W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	PSTM 2018 Abstract Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212178/ http://dx.doi.org/10.1097/01.GOX.0000546733.03805.97

Ejemplares similares

SP03. Pharmacokinetics of Rapamycin and Tacrolimus in Swine Model of Vascularized Composite Allotransplantation
por: Feturi, Firuz G., et al.
Publicado: (2023)

Abstract: Whole Eye Transplantation: Allograft Survival with Tacrolimus Immunosupression and Comparison to Syngeneic Transplantation
por: Chen, Wendy, et al.
Publicado: (2018)

Abstract 41: Adipose-derived Stem Cell-Based Immunomodulatory Therapy in a Translational Porcine Limb Transplant Model
por: Kim, Deokyeol, et al.
Publicado: (2018)

Abstract 39: Characterization And Functional Analysis Of Skin Dendritic Cell Subpopulations In Vascularized Composite Allotransplantation
por: ZHANG, WENSHENG, et al.
Publicado: (2018)

Abstract 37: Whole Eye Allograft Transplantation And Immunosuppression: Survival Of The Transplanted Rodent Eye Using Tacrolimus Monotherapy
por: Chen, Wendy, et al.
Publicado: (2018)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Circulating Donor-derived Cell-free DNA: A Novel Non-invasive Biomarker for Allograft Rejection in Vascularized Composite Allotransplantation
por: Rifkin, William J., et al.
Publicado: (2022)

Abstract: Full Facial Allotransplantation Including the Temporomandibular Joints: An Anatomical Study and Surgical Protocol
por: Nunez-Villaveiran, Teresa, et al.
Publicado: (2018)

Abstract: Study of Retinochoroidal Circulation with Fluorescein Angiography after Whole Eye Transplantation in Rodents
por: Komatsu, Chiaki, et al.
Publicado: (2018)

A Single Cell and Spatial Transcriptomics Approach to Elucidating CD8 T Cells in Vascularized Composite Allotransplantation Rejection
por: Cassidy, Michael, et al.
Publicado: (2023)

RNA Sequencing Reveals a Conserved Mechanism of T Cell-Mediated Rejection in Vascularized Composite Allotransplantation Across Anatomical Sites
por: Cassidy, Michael, et al.
Publicado: (2023)

Abstract: Local Administration of FK506 with Impregnated Nerve Wraps Accelerates Peripheral Nerve Regeneration
por: Barnett, Joshua M., et al.
Publicado: (2018)

Abstract: Prevention of Ischemic-Reperfusion Injury and Chronic Rejection in a Porcine Vascularized Composite Allotransplantation Model
por: Robbins, Nicholas L., et al.
Publicado: (2017)

Abstract: Revitalizing Structural Cryopreserved Allografts in a Porcine Tibia Defect Model
por: Visser, Noor J., et al.
Publicado: (2018)

Maxillary and Mandibular Healing after Facial Allotransplantation
por: Chang, Irene, et al.
Publicado: (2022)

A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal Allotransplantation
por: Sommer, Wiebke, et al.
Publicado: (2021)

Abstract: Development of Injectable Allograft Adipose Matrix for Soft Tissue Filling: From Conception to Clinical Trial
por: Egro, Francesco M., et al.
Publicado: (2018)

Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation
por: Starzl, Ravi, et al.
Publicado: (2013)

Split Rejection in Vascularized Composite Allotransplantation
por: Sinha, Indranil, et al.
Publicado: (2013)

Conversion from tacrolimus to belatacept improves renal function in kidney transplant patients with chronic vascular lesions in allograft biopsy
por: Pérez-Sáez, María José, et al.
Publicado: (2018)

CD28 Family and Chronic Rejection: “To Belatacept...and Beyond!”
por: Silva, Marcos V., et al.
Publicado: (2012)

3281 Management of Acute Rejection in Penile Allotransplantation
por: Jonczyk, Michael, et al.
Publicado: (2019)

Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection
por: Wu, Qianni, et al.
Publicado: (2019)

Abstract 84: Single Locally Implanted Tacrolimus Disk Promotes Long-term Vascularized Composite Allograft Survival via Site Specific Immunosuppression and without Systemic Side Effects
por: Feturi, Firuz G., et al.
Publicado: (2019)

Immunosuppressive protocols with tacrolimus after cryopreserved aortal allotransplantation in rats
por: Spunda, Rudolf, et al.
Publicado: (2018)

Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunction
por: Gallo, Ester, et al.
Publicado: (2020)

Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection
por: Ippoliti, Giovanbattista, et al.
Publicado: (2012)

Abstract 38: Ex Vivo Expanded Regulatory T Cells Combined With Short-term Costimulation Blockade To Prevent Rejection Of Vascularized Composite Allografts
por: Grzelak, Michael J., et al.
Publicado: (2018)

The Effect of Local Exosomes, Stem Cells and Tacrolimus on Neurite Extension
por: Saffari, Tara Sara, et al.
Publicado: (2023)

Immunological Monitoring of Renal Transplant Recipients to Predict Acute Allograft Rejection Following the Discontinuation of Tacrolimus
por: Kreijveld, Ellen, et al.
Publicado: (2008)

Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine
por: Kamel, Mahmoud, et al.
Publicado: (2016)

Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft Rejection
por: Shen, Chia-Lin, et al.
Publicado: (2017)

A chronic rejection model and potential biomarkers for vascularized composite allotransplantation
por: Puscz, Flemming, et al.
Publicado: (2020)

TRFs and tiRNAs sequence in acute rejection for vascularized composite allotransplantation
por: Fang, Yuan, et al.
Publicado: (2022)

Potential Roles of miRNAs in Acute Rejection for Vascularized Composite Allotransplantation
por: Li, Haibo, et al.
Publicado: (2022)

Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome
por: Tatapudi, Vasishta S., et al.
Publicado: (2018)

Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation
por: Gupta, Gaurav, et al.
Publicado: (2010)

Combined Immunotherapy With Belatacept and BTLA Overexpression Attenuates Acute Rejection Following Kidney Transplantation
por: Zhang, Hengcheng, et al.
Publicado: (2021)

Defining chronic rejection in vascularized composite allotransplantation—The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation
por: Kaufman, Christina L, et al.
Publicado: (2020)

Abstract QS29: Study of the Retinochoroidal Circulation with Fluorescein Angiography in a Rodent Orthotopic Whole Eye Transplantation Model
por: Komatsu, Chiaki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r8h5s8r25knqnfc364vepoe9st